EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Future treatments in hypertension: Can we meet the unmet needs of patients?

Mehmet Kanbay, Sidar Copur, Cem Tanriover, Duygu Ucku, Luke Laffin

European Journal of Internal Medicine · 2023

DOI: 10.1016/j.ejim.2023.06.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Internal Medicine, 2023. Verfasst von Mehmet Kanbay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey. Electronic address: mkanbay@ku.edu.tr. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 147 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of arterial hypertension is approximately 47% in the United States and 55% in Europe. Multiple different medical therapies are used to treat hypertension including diuretics, beta blockers, calcium channel blockers, angiotensin receptor blockers, angiotensin converting enzyme inhibitors, alpha blockers, central acting alpha receptor agonists, neprilysin inhibitors and vasodilators. However, despite the numerous number of medications, the prevalence of hypertension is on the rise, a considerable proportion of the hypertensive population is resistant to these therapeutic modalities and a definitive cure is not possible with the current treatment approaches. Therefore, there is a need for novel therapeutic strategies to provide better treatment and control of hypertension. In this review, our aim is to describe the latest developments in the treatment of hypertension including novel medication classes, gene therapies and RNA-based modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertensionHumansUnited StatesAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersAdrenergic beta-AntagonistsDiureticsAngiotensin Receptor Antagonists

Stichwörter der Autor:innen

Aldosterone synthase inhibitorsDual endothelin antagonistsGene-based therapies in hypertensionHypertensionhypertension management

Substanzen

Antihypertensive AgentsAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersAdrenergic beta-AntagonistsDiureticsAngiotensin Receptor Antagonists

Autor:innen und Institutionen

  • Department of Medicine, Division of Nephrology, Koc University School of Medicine, Istanbul, Turkey. Electronic address: mkanbay@ku.edu.tr.
  • Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.

Zitieren

APA

Kanbay, M., Copur, S., Tanriover, C., Ucku, D., & Laffin, L. (2023). Future treatments in hypertension: Can we meet the unmet needs of patients?. European Journal of Internal Medicine. https://doi.org/10.1016/j.ejim.2023.06.008

Vancouver

Kanbay M, Copur S, Tanriover C, Ucku D, Laffin L. Future treatments in hypertension: Can we meet the unmet needs of patients?. European Journal of Internal Medicine. 2023. doi:10.1016/j.ejim.2023.06.008

BibTeX
@article{Kanbay2023,
  author = {Kanbay, Mehmet and Copur, Sidar and Tanriover, Cem and Ucku, Duygu and Laffin, Luke},
  title = {Future treatments in hypertension: Can we meet the unmet needs of patients?},
  journal = {European Journal of Internal Medicine},
  year = {2023},
  doi = {10.1016/j.ejim.2023.06.008}
}
Kostenlos starten →